Table 1 Baseline characteristics
LNG-IUS (N = 209) | |
|---|---|
Study arm | |
Cohort | 87 (42%) |
RCT | 122 (58%) |
Age (mean ± SD) | 44.7 ± 4.8 |
Age ≤ 45 | 97 (46%) |
Age > 45 | 112 (54%) |
BMI (mean ± SD) | 27.4 ± 5.6 |
BMI < 25 | 58 (39%) |
BMI ≥ 25 | 91 (61%) |
Previous vaginal delivery | 159 (81%) |
Previous caesarean section | 34 (17%) |
Previous polypectomy/ myomectomy | 13 (6.3%) |
Tubal ligation | 5 (2.4%) |
Previous LNG-IUS* | 19 (9.3%) |
Previous treatment HMB† | 100 (48%) |
Non-hormonal treatment | 33 (16%) |
Hormonal treatment | 81 (39%) |
Anticoagulants | 10 (4.8%) |
Dysmenorrhea | 139 (71%) |
Mild | 36 (18%) |
Moderate | 59 (30%) |
Severe | 44 (22%) |
PBAC-score (median-IQR) | 425 (288–744) |
Bleeding days (median-IQR) | 8 (6–11) |